EllaJoanneDalyMD

Physician

Dr. Daly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies.
Randall L Morrison, Jaskaran Singh, Ella Daly, Maggie Fedgchin, Rachel Ochs-Ross
The International Journal of Neuropsychopharmacology. 2024-11-01
4 citations
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.
Ibrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, Stephane Borentain, Matthew Macaluso
Psychiatry Research. 2023-05-01
7 citations
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
Manish K Jha, David J Williamson, Ghazal Magharehabed, Ibrahim Turkoz, Ella J Daly
Journal of Affective Disorders. 2023-01-15

Adjunctive Intranasal Esketamine in Treatment-Resistant Depression—ReplyJuly 2018
S114. Efficacy and Safety of Intranasal Esketamine plus an Oral Antidepressant in Elderly Patients with Treatment-Resistant DepressionApril 2018